# Apatinib and Chemotherapy Sequential Treatment With Cervical Cancer

> **NCT03029013** · NA · UNKNOWN · sponsor: **Third Military Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Apatinib

## Key facts

- **NCT ID:** NCT03029013
- **Lead sponsor:** Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2019-12
- **Final completion:** 2020-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03029013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03029013, "Apatinib and Chemotherapy Sequential Treatment With Cervical Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03029013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*